Ress Life Investments A/S
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments
Nybrogade 12
DK-1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 15 April 2025
Corporate Announcement 13/2025
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments A/S publishes the Net Asset Value (NAV) per share as of 31 March 2025.
NAV per share in USD: 2613.83
The performance during March is 0.55% in USD. The year-to-date net performance is 0.72 % in USD. The return in March is positively affected by policy payouts.
Assets under management (AUM) are 264.0 million USD.
The NAV per share in EUR is published on the website of Nasdaq Copenhagen under the section AIF Companies and Funds, where the bid and ask prices are published. The daily NAV in EUR is calculated as the most recently published NAV in USD divided by the European Central Bank’s EUR/USD reference rate on the relevant day.
Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 8 545 282 27
Note: The terms for subscription of shares, minimum subscription amount and redemption of shares are provided in the Articles of Association, Information Brochure and in the Key Information Document available on the Company's website, www.resslifeinvestments.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Tresu Investment Holding A/S16.4.2025 14:21:02 CEST | Press release
Tresu Investment Holding A/S – Update to Financial calendar 2025
BTS GROUP AB16.4.2025 14:00:00 CEST | Press release
Notice to the Annual General Meeting
PARKEN Sport & Entertainment A/S16.4.2025 13:59:47 CEST | Press release
Indstilling af nyt bestyrelsesmedlem
Iveco Group N.V.16.4.2025 13:45:00 CEST | Press release
Iveco Group announces the results of the Annual General Meeting
AccuStem Sciences, Inc.16.4.2025 13:00:00 CEST | Press release
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom